PMVP today
$1.22-$0.04 (-3.57%)close Nov 12, 2026Trend
DailyUptrend (confirmed)
4 hourSymmetric Triangle
1 hourStrong Bearish
15 minLeaning Bearish
5 minLeaning Bullish
Daily trend turns down below $1.03
Key levels
Resistance$1.73
Resistance$1.44
Support$1.21
Support$1.04
Latest news & SEC filings
EarningsPMV Pharmaceuticals Posts Q3 2026 Results
EarningsPMV Pharma posts wider quarterly loss than analysts expected
SEC FilingPMV Pharmaceuticals, Inc. filed a report on a major company event (Form 8-K)
All PMVP news →About PMV Pharmaceuticals
PMV Pharmaceuticals is a clinical-stage biopharmaceutical company that develops small molecule therapies targeting p53 mutations in cancer. Its lead product candidate, rezatapopt, is being studied in clinical trials for tumor-agnostic indications. The company's customers are ultimately patients and healthcare providers, and it operates primarily in the United States.
Based on the company's 10-K filed Mar 6, 2026.
Nasdaq · Healthcare
PMV Pharmaceuticals, Inc. (PMVP)
What Is the Price Target for PMVP?
SEPT Low Target
$5.00
SEPT Mid Target
$5.00
SEPT High Target
$5.00
Analyst Consensus
$5.00
Is PMVP a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PMVP.
Start Free Trial →Is PMVP Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$4.62
12
Moat Score
NONE
1/9
Piotroski Score
-3.4
Altman Z-Score
What Is Smart Money Doing with PMVP?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →PMVP Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-29.82%
FCF Growth YoY
-41.7%
Revenue Trend
UNKNOWN
Dark Pool Trades for PMVP
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for PMVP, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:42:03 | $1.21 | 1,000 | $$1K | SELL |
| 20:30:46 | $1.22 | 1,700 | $$2K | BUY |
| 19:37:21 | $1.22 | 6,820 | $$8K | SELL |
| 18:11:20 | $1.24 | 1,960 | $$2K | BUY |
| 17:13:23 | $1.25 | 4,600 | $$6K | MIDPOINT |
5 dark pool trades shown · $$20K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for PMVP
PREVIEWSEPT Investing provides real-time options flow tracking for PMVP, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $2.5 | Apr 16 | 155 | $$3980 | 199 | BLOCK |
| CALL | $2.5 | Apr 16 | 155 | $$5432 | 194 | BLOCK |
2 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for PMV Pharmaceuticals, Inc. (PMVP) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →PMVP — frequently asked questions
What is PMVP stock price today?
PMV Pharmaceuticals, Inc. (PMVP) is at $1.22, down 3.57% (-$0.04) at the Nov 12, 2026 close.
Why is PMVP stock moving today?
Latest PMVP news — Nov 10, 2026: PMV Pharmaceuticals Posts Q3 2026 Results · Nov 10, 2026: PMV Pharma posts wider quarterly loss than analysts expected
What is the PMVP price target?
The average analyst price target for PMVP is $5.00, ranging from $5 to $5, based on 1 analysts. Latest: Oppenheimer maintains on May 13, 2026.
What do analysts rate PMVP?
Analyst ratings for PMVP: 0 Buy, 1 Hold, 0 Sell — consensus Hold.
Did PMVP beat earnings?
PMVP last reported on Aug 14, 2026: EPS -$0.34 vs -$0.39 expected — a beat of 12.3%.
Does PMVP pay a dividend?
PMVP does not currently pay a dividend.
What are PMVP support and resistance levels?
Support: $1.21, $1.04. Resistance: $1.44, $1.73, $1.91.
What are insiders doing with PMVP?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on PMVP?
Nov 10, 2026: PMV Pharmaceuticals Posts Q3 2026 Results · Nov 10, 2026: PMV Pharma posts wider quarterly loss than analysts expected · Nov 10, 2026: PMV Pharmaceuticals, Inc. filed a report on a major company event (Form 8-K)